{"product_id":"biolegend-400122","title":"Biolegend, 400122, APC Mouse IgG1, κ Isotype Ctrl (FC) Antibody, 100tests","description":"\u003cp\u003eThe MOPC-21 immunoglobulin has unknown specificity. The isotype of this antibody is mouse IgG1, κ. This antibody was chosen as an isotype control after screening on a variety of resting, activated, live, and fixed mouse, rat and human tissues.\u003cbr\u003e\n100tests\u003cbr\u003e\nAntibody Type: Monoclonal\u003cbr\u003e\nHost Species: Mouse\u003cbr\u003e\nFormulation: Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA)\u003cbr\u003e\nPreparation: The immunoglobulin was purified by affinity chromatography, and conjugated with APC under optimal conditions.\u003cbr\u003e\nConcentration: Lot-specific (to obtain lot-specific concentration and expiration, please enter the lot number in our Certificate of Analysis online tool.)\u003cbr\u003e\nStorage \u0026amp; Handling: The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.\u003cbr\u003e\nApplication: FC - Quality tested\u003cbr\u003e\nRecommended Usage: Each lot of this mouse IgG1, κ isotype control antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, use the isotype control at the same concentration as your primary antibody. Use our Concentration Lookup tool to find the exact concentrations of your lots of product.\u003cbr\u003e\nExcitation Laser: Red Laser (633 nm)\u003cbr\u003e\nApplication Notes: Additional reported applications (for the relevant formats) include: Intracellular Flow Cytometry (ICFC), Immunocytochemistry (ICC), Immunohistochemistry (IHC), Immunoprecipitation (IP), Western Blotting (WB), Functional Assay (FA)\u003cbr\u003e\nApplication References(PubMed link indicates BioLegend citation): Carlsten M, et al. 2007. Cancer Res. 67:1317. PubMed Smed-Sörensen A, et al. 2008. Blood 111:5037. PubMed (FA) Bunesmann MM, et al. 2011. Am. J. Respir. Cell. Mol. Biol. Epub. PubMed Matsuyama T, et al. 2005. Infect. Immun. 73:1044. (IF) Correia DV, et al. 2011. Blood 118:992. (FC) PubMed Lian IA, et al. 2011. Placenta. 32:823. PubMed Bufe B, et al. 20015. J Biol Chem. 290:7369. PubMed\u003cbr\u003e\nProduct Citations: Sreevalsan S, et al. 2020. EMBO Rep. 21:e50155. PubMed Fan Y, et al. 2021. Stem Cell Res Ther. 207:12. PubMed Campbell KA, et al. 2023. Commun Biol. 6:264. PubMed Theodoraki MN, et al. 2023. Oncol Lett. 25:200. PubMed Hu X, et al. 2023. Nat Biotechnol. . PubMed Imai H, et al. 2023. iScience. 26:106822. PubMed Park J, et al. 2021. Exp Ther Med. 22:808. PubMed Bhatt RS, et al. 2021. Cancer Immunol Res. 9:156. PubMed Oh S, et al. 2022. Pediatr Int. :e15390. PubMed Zhang X, et al. 2022. Commun Biol. 5:1332. PubMed Le TA, et al. 2022. Mol Ther Nucleic Acids. 30:621. PubMed Gerace D, et al. 2023. Cell Rep Med. 4:100879. PubMed Iancu O, et al. 2023. Mol Ther Nucleic Acids. 31:105. PubMed Gao Y, et al. 2023. JCI Insight. 8: . PubMed Siebert N, et al. 2014. PLoS One. 9:107692. PubMed Haynes A, et al. 2018. J Appl Physiol (1985). 125:401. PubMed Stepanenko AA, et al. 2021. Sci Rep. 11:16088. PubMed Machata S, et al. 2021. Front Immunol. 11:565869. PubMed Eleftheriadis T, et al. 2021. Int J Mol Sci. 22:. PubMed Evren E, et al. 2020. Immunity. 54(2):259-275.e7. PubMed Bagheri V et al. 2018. Journal of cellular physiology. 233(10):7036-7046 . PubMed Heusinger E, et al. 2018. J Virol. 92:18. PubMed Soriani A, et al. 2009. Blood. 113:3503. PubMed Ruetsche D, et al. 2022. Cells. 11:. PubMed Kobayashi Y, et al. 2020. Int J Oncol. 999:56. PubMed Presle A, et al. 2021. Current Biology. 31(10):2203-2213.e5. PubMed Sugita S, et al. 2016. Stem Cell Reports. 7:619-634. PubMed Berical A, et al. 2022. Nat Commun. 13:4270. PubMed Li B, et al. 2019. Stem Cell Res Ther. 10:257. PubMed Aldeghaither DS, et al. 2019. Cancer Immunol Res. 7:230. PubMed Liang Y, et al. 2019. J Allergy Clin Immunol. 144:1025. PubMed Grandclaudon M, et al. 2019. Cell. 179:432. PubMed Niu M, et al. 2021. Nat Commun. 12:5919. PubMed Stepanenko AA, et al. 2022. Mol Ther Oncolytics. 24:230. PubMed Sarcar B, et al. 2022. Mol Cell Proteomics. :100438. PubMed Xiong H, et al. 2021. Theranostics. 11:1594. PubMed Theodoraki MN, et al. 2021. Br J Cancer. 125:1677. PubMed Al-Akhrass H,et al. 2017. Nat Commun. . 10.1038\/s41467-017-01172-5. PubMed Shnayder M, et al. 2020. eLife. 9:e52168.. PubMed Buffalo CZ, et al. 2020. Cell Host \u0026amp; Microbe. 26(3):359-368. PubMed Yoshida R, et al. 2022. Cancer Res. :. PubMed Suzuki S, et al. 2021. STAR Protocols. 2:100683. PubMed Simon Langer et al. 2019. eLife. 8 pii: e41930. PubMed Zapatero–Belinchón FJ, et al. 2019. Viruses. 11:3. PubMed Taouk G, et al. 2019. Sci Rep. 9:8756. PubMed Wong GK, et al. 2019. JCI Insight. 4. PubMed Adhikaree J, et al. 2019. Oncoimmunology. 8:1593803. PubMed Liu Y, et al. 2018. Cancer Cell. 33:480. PubMed Medapati MR, et al. 2021. FASEB J. 35:e21375. PubMed Hawkins FJ, et al. 2020. Cell Stem Cell. 28(1):79-95.e8. PubMed Song S, et al. 2021. Front Immunol. 12:705140. PubMed Hara T, et al. 2021. Cancer Cell. 39(6):779-792.e11. PubMed Zhang HC, et al. 2018. Int J Mol Med. 41:13. PubMed Rambaldi B, et al. 2022. Haematologica. 107:2617. PubMed Samuel RM, et al. 2020. Cell Stem Cell. 27:876. PubMed Chijimatsu R, et al. 2022. Regen Ther. 21:52. PubMed Uranowska K, et al. 2021. Oncol Rep. 1.875. PubMed\u003cbr\u003e\nRRID: AB_326443 (BioLegend Cat. No. 400121) AB_326443 (BioLegend Cat. No. 400122)\u003cbr\u003e\nGene ID: NA\u003cbr\u003e\nClone: MOPC-21\u003cbr\u003e\nRegulatory Status: RUO\u003cbr\u003e\nIsotype: Mouse IgG1, κ\u003c\/p\u003e","brand":"Biolegend","offers":[{"title":"Default Title","offer_id":46866143641769,"sku":"400122","price":0.99,"currency_code":"USD","in_stock":true}],"url":"https:\/\/iright.com\/es\/products\/biolegend-400122","provider":"Iright","version":"1.0","type":"link"}